Please assess the completion status of the following clinical trial:

Trial Title: Genetically Informed Smoking Cessation Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult (≥21 years of age), seeking treatment for smoking cessation.~2. Able to speak English,~3. Active smoking (Cigarettes Per Day (CPD) ≥5), and exhaled Carbon Monoxide (CO) ≥8 ppm~4. Agree to participate in this randomized smoking cessation trial with follow up assessments up to 12 months.~Exclusion Criteria:~1. Pregnancy or breast feeding,~2. Active use or recent use (\< or equal to 1 month) of medication or e-cigarettes for nicotine dependence/smoking cessation, or use of e-cigarettes for more than 9 days in the prior month,~3. Allergy to nicotine patch, lozenge, or varenicline,~4. Unwillingness to prevent pregnancy during the medication phase and 1 month afterwards (women only),~5. Significant cardiac conditions (myocardial infarction, unstable angina, coronary angioplasty, cardiac bypass) or serious arrhythmia in past 6 months,~6. Current heavy alcohol consumption (≥6 drinks/day, 6 days/week),~7. Active psychosis or poorly controlled depression within the past 6 months,~8. Any prior suicide attempt or suicidal ideation within the past 6 months,~9. End stage renal disease with hemodialysis.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Combination NRT and Counseling (Type: ACTIVE_COMPARATOR): Combination Nicotine replacement therapy (cNRT) (patch and lozenge) and smoking cessation counseling will be provided to participants. Lozenges will be given for 12 weeks with a 1 week pre-quit titration and patch for 12 weeks. Seven smoking counseling sessions will be given during treatment.
- Varenicline (Chantix) and Counseling (Type: ACTIVE_COMPARATOR): Varenicline (pill) and smoking cessation counseling will be provided to participants for 12 weeks with 1 week pre-quit titration. Seven smoking cessation counseling sessions will be given during treatment.
- Placebo Medicine and Counseling (Type: PLACEBO_COMPARATOR): Placebo pill and smoking cessation counseling will be provided to participants for 12 weeks with 1 week pre-quit titration. Placebo lozenges will be given for 12 weeks with a 1 week pre-quit titration and patch for 12 weeks. Seven smoking counseling sessions will be given during treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).